Clearside Biomedical, Inc. (CLSD) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Clearside Biomedical, Inc. (CLSD).

Download PennyGems on Google Play Download PennyGems on the App Store

Equity Overview

Price & Market Data

Price: $0.408

Daily Change: -$0.0189 / 4.63%

Daily Range: $0.40 - $0.428

Market Cap: $32,039,212

Daily Volume: 286,508

Performance Metrics

1 Week: -8.38%

1 Month: -50.49%

3 Months: -52.06%

6 Months: -57.86%

1 Year: -62.86%

YTD: -56.60%

Company Details

Employees: 32

Sector: Health technology

Industry: Pharmaceuticals: major

Country:

Details

Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide injectable suspension for the treatment of macular edema associated with uveitis. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which has completed Phase 2 clinical trial to treat wet AMD. The company has a collaboration with bausch + lomb ireland limited, Arctic Vision (Hong Kong) Limited, REGENXBIO, Inc., BioCryst Pharmaceuticals, Inc., and Aura Biosciences, Inc. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.

Selected stocks

Trident Digital Tech Holdings Ltd - American Depository Shares (TDTH)

180 Life Sciences Corp. (ATNF)

Opendoor Technologies Inc (OPEN)